Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms

27 Nov 2021

Abstract excerpt

BACKGROUND: COVID-19 has caused millions of deaths globally, yet the cellular mechanisms underlying the various effects of the disease remain poorly understood. Recently, a new analytical platform for comprehensive analysis of plasma protein profiles using proximity extension assays combined with next generation sequencing has been developed, which allows for multiple proteins to be analyzed simultaneously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34844191
DOI: 10.1016/j.ebiom.2021.103723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsPMID 34844191Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read ↗

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Precise blood proteome profiling in an undiagnosed population with COVID-19Semantic proximity Read ↗

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsSemantic proximity Read ↗

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity AssessmentSemantic proximity Read ↗

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read ↗

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read ↗

Proteomic blood profiling in mild, severe and critical COVID-19 patientsSemantic proximity Read ↗

Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.